Highly Effective mRNA-Based Malaria Vaccine to Undergo Clinical Trial by End of 2022, BioNTech Announces Medicine & Technology Jul 27, 2021 BioNTech announces its plans on developing a highly effective mRNA-based malaria vaccine after the success of the mRNA COVID-19 vaccine that they co-developed with Pfizer. What could the public expect from this?
Space Weather Alert: NOAA Warns of a Solar Radiation Storm With 60% Chance of Hitting the Earth This Week
Project Hephaistos: Scientists Claim To Have Detected Technosignatures From Dyson Spheres of Alien Civilization
SPACE NASA's Juno Mission Releases New Photos Featuring Great Red Spot, Potato-Like Shape Moon Amalthea